PI
ENZ

PFG Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

PFG Investments’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,662
Closed -$23.7K – 1112
2024
Q1 		$23.7K Buy
+18,662
New +$24.6K ﹤0.01% 1018

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

PFG Investments's ENZ Position: Q2 2024 in Review

PFG Investments sold out of Enzo Biochem, Inc. (ENZ) in Q2 2024, closing a stake of 18,662 shares — an estimated $23.7K sold.

PFG Investments first reported a position in ENZ in Q1 2024 and held it in 1 quarter. The position peaked at $23.7K in Q1 2024. 39 funds tracked by Wall St. Rank hold ENZ as of Q2 2024.

  • PFG Investments reported no remaining Enzo Biochem, Inc. position as of Q2 2024 after selling out during the quarter.
  • PFG Investments sold 18,662 Enzo Biochem, Inc. shares in Q2 2024, an estimated $23.7K.
  • PFG Investments first reported a position in Enzo Biochem, Inc. in Q1 2024 and held it in 1 quarter.
  • PFG Investments's Enzo Biochem, Inc. position peaked at $23.7K in Q1 2024.
  • 39 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2024.

Based on PFG Investments's 13F filing for Q2 2024, filed 7 Aug 2024.